Insider Transactions in Q2 2023 at Agios Pharmaceuticals, Inc. (AGIO)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Brian Goff Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,449
-44.85%
|
$320,572
$28.36 P/Share
|
|
Jun 30
2023
|
Sarah Gheuens Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,707
-6.6%
|
$47,796
$28.36 P/Share
|
|
Jun 30
2023
|
Jacqualyn A Fouse Director |
SELL
Open market or private sale
|
Direct |
10,718
-9.11%
|
$300,104
$28.36 P/Share
|
|
Jun 30
2023
|
James William Burns Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,707
-5.34%
|
$47,796
$28.36 P/Share
|
|
Jun 30
2023
|
Tsveta Milanova Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,618
-29.69%
|
$45,304
$28.36 P/Share
|
|
Jun 30
2023
|
Cecilia Jones Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,597
-29.68%
|
$44,716
$28.36 P/Share
|
|
Jun 28
2023
|
Brian Goff Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,528
+50.0%
|
-
|
|
Jun 28
2023
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,750
+18.19%
|
-
|
|
Jun 28
2023
|
Jacqualyn A Fouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
23,900
+16.88%
|
-
|
|
Jun 28
2023
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,750
+15.24%
|
-
|
|
Jun 28
2023
|
Tsveta Milanova Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,449
+50.0%
|
-
|
|
Jun 28
2023
|
Cecilia Jones Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,380
+50.0%
|
-
|
|
Jun 21
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,975
+3.89%
|
-
|
|
Jun 21
2023
|
David Scadden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,975
+29.14%
|
-
|
|
Jun 21
2023
|
Maykin Ho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,975
+30.15%
|
-
|
|
Jun 21
2023
|
Kaye I Foster Cheek Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,975
+30.15%
|
-
|
|
Apr 12
2023
|
Jacqualyn A Fouse Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,731
-4.8%
|
$99,351
$21.35 P/Share
|
|
Apr 08
2023
|
Jacqualyn A Fouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,933
+13.92%
|
-
|
|
Apr 03
2023
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
16,363
-12.19%
|
$359,986
$22.85 P/Share
|
|
Apr 03
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,363
+10.86%
|
$147,267
$9.05 P/Share
|